Genprex Statistics
Total Valuation
Genprex has a market cap or net worth of $3.69 million. The enterprise value is -$14.36 million.
| Market Cap | 3.69M |
| Enterprise Value | -14.36M |
Important Dates
The next estimated earnings date is Thursday, August 13, 2026, after market close.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Genprex has 481,199 shares outstanding.
| Current Share Class | 481,199 |
| Shares Outstanding | 481,199 |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +229.76% |
| Owned by Insiders (%) | 0.21% |
| Owned by Institutions (%) | 1.03% |
| Float | 480,211 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.19 |
| P/TBV Ratio | 0.22 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.61
| Current Ratio | 5.61 |
| Quick Ratio | 5.38 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -21.68 |
Financial Efficiency
Return on equity (ROE) is -160.84% and return on invested capital (ROIC) is -96.41%.
| Return on Equity (ROE) | -160.84% |
| Return on Assets (ROA) | -76.19% |
| Return on Invested Capital (ROIC) | -96.41% |
| Return on Capital Employed (ROCE) | -94.62% |
| Weighted Average Cost of Capital (WACC) | -0.76% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.29M |
| Employee Count | 13 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -97.62% in the last 52 weeks. The beta is -0.91, so Genprex's price volatility has been lower than the market average.
| Beta (5Y) | -0.91 |
| 52-Week Price Change | -97.62% |
| 50-Day Moving Average | 14.32 |
| 200-Day Moving Average | 67.09 |
| Relative Strength Index (RSI) | 28.71 |
| Average Volume (20 Days) | 34,067 |
Short Selling Information
| Short Interest | 938,287 |
| Short Previous Month | 1.00M |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.44 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -16.04M |
| Pretax Income | -16.73M |
| Net Income | -16.73M |
| EBITDA | n/a |
| EBIT | -16.04M |
| Earnings Per Share (EPS) | -$141.83 |
Balance Sheet
The company has $18.05 million in cash and n/a in debt, with a net cash position of $18.05 million or $37.51 per share.
| Cash & Cash Equivalents | 18.05M |
| Total Debt | n/a |
| Net Cash | 18.05M |
| Net Cash Per Share | $37.51 |
| Equity (Book Value) | 16.93M |
| Book Value Per Share | 41.18 |
| Working Capital | 15.45M |
Cash Flow
| Operating Cash Flow | -14.29M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -14.29M |
| FCF Per Share | -$29.69 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Genprex does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -453.19% |
| FCF Yield | -387.13% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 16, 2026. It was a reverse split with a ratio of 1:22.
| Last Split Date | Jul 16, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:22 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |